These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer. Aghdam AM; Amiri A; Salarinia R; Masoudifar A; Ghasemi F; Mirzaei H Crit Rev Eukaryot Gene Expr; 2019; 29(2):127-139. PubMed ID: 31679268 [TBL] [Abstract][Full Text] [Related]
9. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127 [TBL] [Abstract][Full Text] [Related]
10. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer. Kachakova D; Mitkova A; Popov E; Popov I; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis. Yin C; Fang C; Weng H; Yuan C; Wang F Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818 [TBL] [Abstract][Full Text] [Related]
12. Virus encoded circulatory miRNAs for early detection of prostate cancer. Kim J; Yun SJ; Kim WJ BMC Urol; 2015 Nov; 15():116. PubMed ID: 26612689 [TBL] [Abstract][Full Text] [Related]
13. MicroRNAs Role in Prostate Cancer. Balacescu O; Dumitrescu RG; Marian C Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics. Gordanpour A; Nam RK; Sugar L; Seth A Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688 [TBL] [Abstract][Full Text] [Related]
15. Combining PHI and miRNAs as Biomarkers in Prostate Cancer Diagnosis and Prognosis. Ibrahim NH; Abdellateif MS; Thabet G; Kassem SH; El-Salam MA; El-Leithy AA; Selim MM Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307177 [TBL] [Abstract][Full Text] [Related]
17. miRNAs as biomarkers in prostate cancer. Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165 [TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. Zhang YC; Xu Z; Zhang TF; Wang YL World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic significance of miR-21, miR-141, miR-18a and miR-221 as novel biomarkers in prostate cancer among Egyptian patients. Ibrahim NH; Abdellateif MS; Kassem SH; Abd El Salam MA; El Gammal MM Andrologia; 2019 Nov; 51(10):e13384. PubMed ID: 31483058 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer. Azani A; Omran SP; Ghasrsaz H; Idani A; Eliaderani MK; Peirovi N; Dokhani N; Lotfalizadeh MH; Rezaei MM; Ghahfarokhi MS; KarkonShayan S; Hanjani PN; Kardaan Z; Navashenagh JG; Yousefi M; Abdolahi M; Salmaninejad A Pathol Res Pract; 2023 Aug; 248():154618. PubMed ID: 37331185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]